Free Trial
NASDAQ:KMTS

Kestra Medical Technologies (KMTS) Stock Price, News & Analysis

Kestra Medical Technologies logo
$15.67 +0.42 (+2.75%)
As of 07/3/2025 01:00 PM Eastern

About Kestra Medical Technologies Stock (NASDAQ:KMTS)

Key Stats

Today's Range
$14.67
$15.84
50-Day Range
$15.03
$25.12
52-Week Range
$14.15
$26.15
Volume
197,689 shs
Average Volume
423,301 shs
Market Capitalization
$804.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$27.50
Consensus Rating
Moderate Buy

Company Overview

Receive KMTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kestra Medical Technologies and its competitors with MarketBeat's FREE daily newsletter.

KMTS Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
Kestra Medical: Skipping A Heartbeat
See More Headlines

KMTS Stock Analysis - Frequently Asked Questions

Kestra Medical Technologies' stock was trading at $20.99 at the beginning of the year. Since then, KMTS stock has decreased by 25.3% and is now trading at $15.67.

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) announced its quarterly earnings results on Monday, April, 14th. The company reported ($1.25) EPS for the quarter, missing analysts' consensus estimates of ($0.64) by $0.61.
Read the conference call transcript
.

Kestra Medical Technologies (KMTS) raised $202 million in an initial public offering on Thursday, March 6th 2025. The company issued 11,882,352 shares at a price of $17.00 per share.

Kestra Medical Technologies's lock-up period expires on Tuesday, September 2nd. Kestra Medical Technologies had issued 11,882,352 shares in its public offering on March 6th. The total size of the offering was $201,999,984 based on an initial share price of $17.00. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the expiration of the lock-up period.

Shares of KMTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
4/14/2025
Today
7/04/2025
Fiscal Year End
4/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:KMTS
Previous Symbol
NASDAQ:KMTS
Web
N/A
Fax
N/A
Employees
300
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$27.50
High Stock Price Target
$30.00
Low Stock Price Target
$23.00
Potential Upside/Downside
+75.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
6 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$52.64 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$804.64 million
Optionable
N/A
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:KMTS) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners